COMPANY NEWS


Biocon Ltd
BSE Code 532523 ISIN Demat INE376G01013 Book Value (₹) 90.88 NSE Symbol BIOCON Div & Yield % 0.16 Market Cap ( Cr.) 36,720.35 P/E * 339.83 EPS * 0.9 Face Value (₹) 5
* Profit to Earning Ratio
* Earning Per Share
Biocon Biologics divests its non-crore branded formulations biz in India Back
(10 Nov 2023)
Biocon Biologics, a subsidiary of Biocon has divested the businesses in relation to its non-core branded formulations in India, comprising, inter alia, of generic dermatology and nephrology small molecule formulations (BFI Non-Core Business) to Eris Lifesciences on a ‘slump sale' basis.